CytImmune is a biotechnology company that has invented, patented, and developed a set of novel technologies with the potential to treat up to 85% of all cancers. Our IO+ platform turns hot tumors cold, remodels the tumor microenvironment, and kills cancer cells.
View Top Employees from Cytimmune SciencesWebsite | http://www.cytimmune.com |
Revenue | $1 million |
Employees | 7 (7 on RocketReach) |
Founded | 2005 |
Address | 15010 Broschart Road, Rockville, Maryland 20850, US |
Phone | (301) 825-3041 |
Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Health Care, Pharmaceutical |
Web Rank | 16 Million |
Competitors | Galmed Pharmaceuticals Ltd., Genetic Immunity, LLC, Nanobiosym, Precision Biologics, Sequella, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Cytimmune Sciences employee's phone or email?
The Cytimmune Sciences annual revenue was $1 million in 2024.
Saba Malak is the Chief Executive Officer, Chairman of Cytimmune Sciences.
7 people are employed at Cytimmune Sciences.
Cytimmune Sciences is based in Rockville, Maryland.
The NAICS codes for Cytimmune Sciences are [32, 325, 32541, 3254].
The SIC codes for Cytimmune Sciences are [28, 283].